Bioscript Announces Two Acquisitions

Pharmaceutical communications company Bioscript has announced two strategic acquisitions: Fortis Pharma Consulting, a London-based specialist in medical affairs services, and Valid Insight, a market access consultancy that develops global and regional access and pricing strategies, together with payer research, advisory boards and value communication services.

Commenting on the strategic business expansion, Andrew Medley, CEO of Bioscript Group, said: ”At a time of greater trial complexity, rising evidence demands, and tougher economic conditions our clients are looking to us to help navigate demanding access environments and optimize launch success.”

“Our clients are increasingly realizing the benefits of integrated services from one strategic partner,” Andrew noted: “it helps them to streamline the product journey by responding dynamically to the evolving external environment through shared knowledge and insights.”

Source: Bioscript.